Retinal Vein Occlusion Initial PBS authority application Supporting information form (PB154)

You must lodge this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with ranibizumab or aflibercept for the treatment of visual impairment due to macular oedema secondary to Branched Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).


Page last updated: 5 February 2016

This information was printed Saturday 1 October 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.